tiprankstipranks
Advertisement
Advertisement

GKOS Stock Latest News

Glaukos Shareholders Reinforce Board, Pay and Auditor Support
Company AnnouncementsGlaukos Shareholders Reinforce Board, Pay and Auditor Support
2d ago
8K
GKOS
Analyst Reiterates Buy on Glaukos, Citing Long-Term iDose Opportunity and Upcoming Epioxa-Driven Growth
PremiumRatings
Analyst Reiterates Buy on Glaukos, Citing Long-Term iDose Opportunity and Upcoming Epioxa-Driven Growth
2d ago
GKOS
Glaukos pullback due to concerns about iDose LCD, says William Blair
PremiumThe Fly
Glaukos pullback due to concerns about iDose LCD, says William Blair
10d ago
GKOS
Steven Lichtman Reiterates Buy on Glaukos, Citing Manageable Coverage Risk and Robust Multiyear iDose Growth Outlook
PremiumRatings
Steven Lichtman Reiterates Buy on Glaukos, Citing Manageable Coverage Risk and Robust Multiyear iDose Growth Outlook
10d ago
GKOS
Glaukos: Buy Rating Reiterated as Favorable iDose LCD Eases Reimbursement Overhang and Sets Stage for Epioxa-Driven Growth
PremiumRatings
Glaukos: Buy Rating Reiterated as Favorable iDose LCD Eases Reimbursement Overhang and Sets Stage for Epioxa-Driven Growth
15d ago
GKOS
Glaukos price target raised to $162 from $141 at BTIG
PremiumThe FlyGlaukos price target raised to $162 from $141 at BTIG
15d ago
GKOS
Glaukos Highlights Growth Strategy in Interventional Eye Care
Premium
Company Announcements
Glaukos Highlights Growth Strategy in Interventional Eye Care
1M ago
8K
GKOS
Glaukos Corp. Risk Profile in Flux as New 10‑Q Disclosures Replace 2025 10‑K, Heightening Uncertainty for Investors
Premium
Company Announcements
Glaukos Corp. Risk Profile in Flux as New 10‑Q Disclosures Replace 2025 10‑K, Heightening Uncertainty for Investors
1M ago
GKOS
Glaukos Corp. Earnings Call Signals Growth Momentum
PremiumCompany Announcements
Glaukos Corp. Earnings Call Signals Growth Momentum
1M ago
GKOS
Glaukos price target raised to $153 from $134 at Goldman Sachs
PremiumThe Fly
Glaukos price target raised to $153 from $134 at Goldman Sachs
1M ago
GKOS
Glaukos price target raised to $170 from $160 at Stifel
PremiumThe Fly
Glaukos price target raised to $170 from $160 at Stifel
1M ago
GKOS
Glaukos price target raised to $140 from $120 at JPMorgan
PremiumThe Fly
Glaukos price target raised to $140 from $120 at JPMorgan
1M ago
GKOS
Glaukos price target raised to $136 from $127 at Needham
PremiumThe FlyGlaukos price target raised to $136 from $127 at Needham
1M ago
GKOS
Glaukos price target raised to $141 from $131 at BTIG
Premium
The Fly
Glaukos price target raised to $141 from $131 at BTIG
1M ago
GKOS
Glaukos price target raised to $140 from $135 at Citi
Premium
The Fly
Glaukos price target raised to $140 from $135 at Citi
1M ago
GKOS
Glaukos Reaffirmed as Buy on Strong Q1 Beat, Raised 2026 Revenue Outlook, and Billion-Dollar Peak Potential for iDose and Epioxa
PremiumRatings
Glaukos Reaffirmed as Buy on Strong Q1 Beat, Raised 2026 Revenue Outlook, and Billion-Dollar Peak Potential for iDose and Epioxa
1M ago
GKOS
Glaukos reports Q1 EPS (18c), consensus (28c)
PremiumThe Fly
Glaukos reports Q1 EPS (18c), consensus (28c)
1M ago
GKOS
Glaukos sees FY26 revenue $620M-$635M, consensus $614.4M
PremiumThe Fly
Glaukos sees FY26 revenue $620M-$635M, consensus $614.4M
1M ago
GKOS
Glaukos Boosts Outlook After Strong First-Quarter 2026 Results
PremiumCompany Announcements
Glaukos Boosts Outlook After Strong First-Quarter 2026 Results
1M ago
8K
GKOS
GKOS Earnings this Week: How Will it Perform?
PremiumPre-EarningsGKOS Earnings this Week: How Will it Perform?
1M ago
GKOS
Glaukos receives permanent J-code for Epioxa
Premium
The Fly
Glaukos receives permanent J-code for Epioxa
2M ago
GKOS
William Blair med tech analyst holds an analyst/industry conference call
Premium
The Fly
William Blair med tech analyst holds an analyst/industry conference call
2M ago
ALC
COO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >